Researchers at BYU have devised a system to speed up the process of making life-saving vaccines for new viruses.
Their concept is to create the biological machinery for vaccine production en masse, put it in a freeze-dried state and stockpile it around the country. Then, when a new virus hits, labs can simply add water to a “kit” to rapidly produce vaccines.
“You could just pull it off the shelf and make it,” said senior author Brad Bundy, associate professor of chemical engineering. “We could make the vaccine and be ready for distribution in a day.”
The research, published in Biotechnology Journal, demonstrates the ability to store the drug and vaccine-making machinery for more than a year.
Traditional systems to produce vaccines for pandemic influenza strains require heavy engineering and specialized equipment that only a few labs across the country have on hand. These traditional systems are also time-consuming, taking months to execute.
Bundy’s idea is a new angle on the emerging method of “cell-free protein synthesis,” a process that combines DNA to make proteins needed for drugs (instead of growing protein in a cell). His lab is creating a system where the majority of the work is done beforehand so vaccine kits can be ready to go and be activated at the drop of a dime.
“It will not only provide a quicker response to pandemics, but it will also make protein-based drugs more available to third-world countries where production and refrigerated storage can be problematic,” added William Pitt, a study coauthor and fellow BYU professor of chemical engineering.
While the team is now testing their version of the cell-free, recombinant DNA process for vaccine production, they’ve already successfully demonstrated it for at least one anti-cancer protein (onconase).
The researchers believe their method can significantly reduce investment of time and money towards future drug production and, in turn, reduce treatment expenses for patients.
“The drugs today are changing,” Bundy said. “The lifesaving cancer drugs we have now, the drugs for arthritis, the drugs with the greatest impact, are made out of proteins, not small chemical molecules. This method takes full advantage of that to provide a quicker, more personal response.”
The Latest on: Making vaccines
via Google News
The Latest on: Making vaccines
- Phoenix pauses COVID-19 vaccine mandate for city workerson December 8, 2021 at 12:41 am
Phoenix paused implementation Tuesday of a federal COVID-19 vaccine mandate for the 14,000 workers in the nation’s fifth largest city, just hours after a federal judge temporarily blocked President ...
- BHP Still Backs Worker Vaccine Mandate, Will Proceed With Reconsultationon December 7, 2021 at 10:37 pm
By Rhiannon Hoyle BHP Group Ltd. signaled that it remains committed to making Covid-19 vaccines mandatory for workers at an Australian coal mine, despite ...
- Judge blocks Biden vaccine mandate for federal contractorson December 7, 2021 at 9:24 pm
A federal judge on Tuesday blocked President Joe Biden's administration from enforcing a COVID-19 vaccine mandate for employees of federal contractors, the latest in a string of victories for ...
- Federal judge slaps down another Biden administration vaccine mandateon December 7, 2021 at 7:16 pm
A federal judge Tuesday blocked a national COVID-19 vaccine mandate that would have required private government contractors to get their shots.
- Africa needs to make own vaccines but hurdles are high, experts sayon December 7, 2021 at 5:11 am
Africa needs to make its own vaccines to avoid a repeat of its supply problems in the COVID-19 pandemic but faces big obstacles in turning itself from a pharmaceutical testing ground into a place ...
- Could numerous boosters make future Covid vaccines less effective? Experts weigh inon December 6, 2021 at 5:17 pm
Federal health officials are urging all vaccinated adults to get their Covid booster shot amid growing alarm over the omicron variant, a heavily mutated coronavirus strain that's already been detected ...
- South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - execon December 6, 2021 at 6:30 am
BioNTech's , COVID-19 vaccine early next year after receiving the drug substance from Europe, a Pfizer executive said on Monday.
- Digital Vaccine Passes Will Soon Be In More Than 30 States — Here’s How That Will Make Travel A Lot Easieron December 6, 2021 at 5:24 am
By early 2022, three out of five states will have digital apps to verify vaccination status. The good news for travelers is that they will be all working together.
- New nanoparticle adjuvant could help make vaccines more powerfulon December 5, 2021 at 9:52 am
A common strategy to make vaccines more powerful is to deliver them along with an adjuvant -; a compound that stimulates the immune system to produce a stronger response.
- Facebook sold ads that compared vaccines to the Holocaust and said 'Make Hanging Traitors Great Again'on December 2, 2021 at 7:42 pm
Facebook made at least $780,000 from selling ads with violent and anti-vaccine messages that compared the US pandemic response to Nazi Germany.
via Bing News